Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Ono discloses cGMP-PDE/TxA2 synthase inhibitors

Nov. 1, 1996

New antiallergic agents from Takeda

Nov. 1, 1996

Pfizer describes a new series of CRF antagonists

Nov. 1, 1996

Japanese researchers disclose glutamate antagonists

Nov. 1, 1996

Meiji Seika discloses compounds that enhance axonal regeneration

Nov. 1, 1996

N-type calcium channel blockers from Sankyo

Nov. 1, 1996

Melatonergic agents reported by BMS

Nov. 1, 1996

Schering AG describes radiographic contrast agent

Nov. 1, 1996

MRI contrast agents from Nycomed Salutar

Nov. 1, 1996

Antiobesity proteins described by Lilly

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...